Literature DB >> 15001810

The serotonergic system and anxiety.

Joshua A Gordon1, Rene Hen.   

Abstract

The wide use of serotonin reuptake inhibitors and serotonin receptor agonists in anxiety disorders has suggested a key role for the modulatory neurotransmitter in anxiety. However, serotonin's specific role is still uncertain. This article reviews the literature concerning how and where serotonergic agents modulate anxiety. Varying and sometimes conflicting data from human and animal studies argue for both anxiolytic and anxiogenic roles for serotonin, depending on the specific disorder, structure, or behavioral task studied. However, recent data from molecular genetic studies in the mouse point toward two important roles for the serotonin 1A receptor. In development, serotonin acts through this receptor to promote development of the circuitry necessary for normal anxiety-like behaviors. In adulthood, serotonin reuptake inhibitors act through the same receptor to stimulate neurogenesis and reduce anxiety-like behaviors. These studies highlight that the complex serotonin system likely plays various roles in the regulation of anxiety both during development and in adulthood.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001810     DOI: 10.1385/NMM:5:1:027

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  102 in total

1.  Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder.

Authors:  J Deckert; M Catalano; Y V Syagailo; M Bosi; O Okladnova; D Di Bella; M M Nöthen; P Maffei; P Franke; J Fritze; W Maier; P Propping; H Beckmann; L Bellodi; K P Lesch
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

2.  Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice.

Authors:  A Evrard; I Malagié; A-M Laporte; C Boni; N Hanoun; A-C Trillat; I Seif; E De Maeyer; A Gardier; M Hamon; J Adrien
Journal:  Eur J Neurosci       Date:  2002-03       Impact factor: 3.386

3.  Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult.

Authors:  Cornelius Gross; Xiaoxi Zhuang; Kimberly Stark; Sylvie Ramboz; Ronald Oosting; Lynn Kirby; Luca Santarelli; Sheryl Beck; René Hen
Journal:  Nature       Date:  2002-03-28       Impact factor: 49.962

4.  Serotonin facilitates GABAergic transmission in the CA1 region of rat hippocampus in vitro.

Authors:  N Ropert; N Guy
Journal:  J Physiol       Date:  1991-09       Impact factor: 5.182

5.  Effect of citalopram, a selective serotonin reuptake inhibitor, on the acquisition of conditioned freezing.

Authors:  T Inoue; S Hashimoto; K Tsuchiya; T Izumi; T Ohmori; T Koyama
Journal:  Eur J Pharmacol       Date:  1996-09-05       Impact factor: 4.432

Review 6.  Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis.

Authors:  R W Fuller
Journal:  Life Sci       Date:  1994       Impact factor: 5.037

7.  Serotonergic and catecholaminergic reuptake inhibitors have opposite effects on the ultrasonic isolation calls of rat pups.

Authors:  J T Winslow; T R Insel
Journal:  Neuropsychopharmacology       Date:  1990-02       Impact factor: 7.853

8.  Serotonin receptor 1A knockout: an animal model of anxiety-related disorder.

Authors:  S Ramboz; R Oosting; D A Amara; H F Kung; P Blier; M Mendelsohn; J J Mann; D Brunner; R Hen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

Review 9.  The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies.

Authors:  L C Barr; W K Goodman; L H Price; C J McDougle; D S Charney
Journal:  J Clin Psychiatry       Date:  1992-04       Impact factor: 4.384

Review 10.  New developments in the neurobiological basis of anxiety disorders.

Authors:  Jack M Gorman; Robert M A Hirschfeld; Philip T Ninan
Journal:  Psychopharmacol Bull       Date:  2002
View more
  54 in total

1.  3β-Methoxy-pregnenolone (MAP4343) as an innovative therapeutic approach for depressive disorders.

Authors:  Massimiliano Bianchi; Etienne-Emile Baulieu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-19       Impact factor: 11.205

2.  Region-specific regulation of 5-HT1A receptor expression by Pet-1-dependent mechanisms in vivo.

Authors:  Kirsten X Jacobsen; Margaret Czesak; Mariam Deria; Brice Le François; Paul R Albert
Journal:  J Neurochem       Date:  2011-01-24       Impact factor: 5.372

Review 3.  Genetic, epigenetic and posttranscriptional mechanisms for treatment of major depression: the 5-HT1A receptor gene as a paradigm

Authors:  Paul R. Albert; Brice Le François; Faranak Vahid-Ansari
Journal:  J Psychiatry Neurosci       Date:  2019-05-01       Impact factor: 6.186

4.  Estrogen decreases 5-HT1B autoreceptor mRNA in selective subregion of rat dorsal raphe nucleus: inverse association between gene expression and anxiety behavior in the open field.

Authors:  R Hiroi; J F Neumaier
Journal:  Neuroscience       Date:  2008-11-01       Impact factor: 3.590

5.  Perisomatic GABA release and thalamocortical integration onto neocortical excitatory cells are regulated by neuromodulators.

Authors:  Illya Kruglikov; Bernardo Rudy
Journal:  Neuron       Date:  2008-06-26       Impact factor: 17.173

6.  Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat.

Authors:  Brittney M Cox; Mrudang M Shah; Teri Cichon; Manuel E Tancer; Matthew P Galloway; David M Thomas; Shane A Perrine
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-10-10       Impact factor: 5.067

7.  Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities.

Authors:  Rodney C Samaco; Caleigh Mandel-Brehm; Hsiao-Tuan Chao; Christopher S Ward; Sharyl L Fyffe-Maricich; Jun Ren; Keith Hyland; Christina Thaller; Stephen M Maricich; Peter Humphreys; John J Greer; Alan Percy; Daniel G Glaze; Huda Y Zoghbi; Jeffrey L Neul
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-09       Impact factor: 11.205

8.  Corticotropin releasing factor induces anxiogenic locomotion in trout and alters serotonergic and dopaminergic activity.

Authors:  Russ E Carpenter; Michael J Watt; Gina L Forster; Øyvind Øverli; Craig Bockholt; Kenneth J Renner; Cliff H Summers
Journal:  Horm Behav       Date:  2007-08-08       Impact factor: 3.587

Review 9.  Animal models of social contact and drug self-administration.

Authors:  Justin C Strickland; Mark A Smith
Journal:  Pharmacol Biochem Behav       Date:  2015-07-06       Impact factor: 3.533

10.  Modifying 5-HT1A Receptor Gene Expression as a New Target for Antidepressant Therapy.

Authors:  Paul R Albert; Brice Le François
Journal:  Front Neurosci       Date:  2010-06-17       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.